Rosetta Genomics' Pending Acquisition

Rosetta Genomics raised a round of funding on December 15, 2017. Investors include Genoptix.

Rosetta Genomics (NASDAQ: ROSG) is a molecular diagnostics company advancing microRNA-based diagnostics discovered and developed through its proprietary microRNAs and platform technologies. Backed by …

Articles about Rosetta Genomics' Pending Acquisition: